BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Tuesday reported a loss of $4.1 million in its third quarter.
The Beverly Hills, California-based company said it had a loss of 14 cents per share.
The biotechnology company posted revenue of $219,200 in the period. Its adjusted revenue was $219,000.
In the final minutes of trading on Tuesday, the company's shares hit 91 cents. A year ago, they were trading at $2.75.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR